Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy
MS Slaughter, Y Naka, R John, A Boyle… - The Journal of Heart and …, 2010 - Elsevier
BACKGROUND: Anti-coagulation with heparin is often used after left ventricular assist
device implantation as a transition to long-term warfarin therapy. We retrospectively
evaluated the effects of heparin use on thromboembolic and bleeding complications after
implantation of the HeartMate II left ventricular assist device (LVAD). METHODS: LVAD
patients (n= 418) implanted as a bridge to transplant were divided into three groups: Group
A patients (therapeutic, n= 118) received heparin and had a partial thromboplastin time …
device implantation as a transition to long-term warfarin therapy. We retrospectively
evaluated the effects of heparin use on thromboembolic and bleeding complications after
implantation of the HeartMate II left ventricular assist device (LVAD). METHODS: LVAD
patients (n= 418) implanted as a bridge to transplant were divided into three groups: Group
A patients (therapeutic, n= 118) received heparin and had a partial thromboplastin time …
以上显示的是最相近的搜索结果。 查看全部搜索结果